3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Follicular
1
Arthritis, Rheumatoid
1
Interventions
RC-18
2
Methotrexate
2
olokizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Arthritis, Rheumatoid
×
olokizumab
×
Lymphoid
×
Clear all
NCT03120949
2023-10-12
CREDO 4
R-Pharm
Phase 3
Completed
2,106 enrolled
30 charts